HK Stock MarketDetailed Quotes

SINO BIOPHARM (01177)

Watchlist

6.950
-0.050-0.71%

Market Closed Jan 16 16:07 CST

130.39BMarket Cap30.75P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SINO BIOPHARM (01177) Income Statement

All

YOY

Hide blank lines

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(Q1)Mar 31, 2021

Turnover

10.71%17.57B

10.18%28.87B

11.14%15.87B

0.67%26.2B

-5.99%14.28B

-3.11%26.03B

5.85%15.19B

13.59%26.86B

13.49%14.35B

16.41%7.24B

Operating income

10.71%17.57B

10.18%28.87B

11.14%15.87B

0.67%26.2B

-5.99%14.28B

-3.11%26.03B

5.85%15.19B

13.59%26.86B

13.49%14.35B

16.41%7.24B

Cost of sales

-8.31%-3.08B

-6.94%-5.34B

-9.42%-2.84B

-11.19%-4.99B

12.16%-2.6B

15.84%-4.49B

-7.50%-2.96B

-2.89%-5.33B

1.39%-2.75B

-11.75%-1.42B

Operating expenses

-8.31%-3.08B

-6.94%-5.34B

-9.42%-2.84B

-11.19%-4.99B

12.16%-2.6B

15.84%-4.49B

-7.50%-2.96B

-2.89%-5.33B

1.39%-2.75B

-11.75%-1.42B

Gross profit

11.24%14.49B

10.94%23.53B

11.52%13.03B

-1.53%21.21B

-4.50%11.68B

0.04%21.54B

5.46%12.23B

16.60%21.53B

17.70%11.6B

17.60%5.83B

Selling expenses

-11.27%-6.45B

-9.62%-10.08B

-11.03%-5.8B

6.28%-9.19B

9.23%-5.22B

6.74%-9.81B

-1.52%-5.75B

-17.23%-10.52B

-22.83%-5.67B

-22.58%-3.05B

Administrative expenses

-4.03%-1.09B

-11.12%-2.08B

-4.58%-1.05B

1.38%-1.87B

14.99%-1.01B

13.08%-1.9B

-4.97%-1.18B

17.72%-2.19B

-6.90%-1.13B

-1.69%-448.06M

Operating interest expense

----

-14.98%-169.27M

4.56%-308.62M

15.55%-147.22M

20.76%-71.66M

Special items of operating profit

51.71%-1.23B

-51.07%-6.18B

-34.58%-2.54B

-1.44%-4.09B

-0.61%-1.89B

-12.79%-4.03B

-48.22%-1.88B

-138.87%-3.58B

7.01%-1.27B

-38.40%-889.49M

Operating profit

57.31%5.72B

-14.23%5.19B

1.96%3.64B

4.40%6.05B

9.70%3.57B

17.31%5.8B

-4.19%3.25B

-1.48%4.94B

27.98%3.39B

5.76%1.36B

Financing income

66.89%373.58M

32.04%499.56M

--223.85M

--378.34M

----

Financing cost

19.86%-123.2M

40.41%-295.12M

47.61%-153.74M

-15.31%-495.24M

---293.43M

---429.49M

----

Share of profits of associates

94.82%-4.82M

77.50%-118.3M

57.59%-93.06M

-243.66%-525.71M

-143.61%-219.44M

-101.12%-152.98M

-93.37%503.16M

421,714.29%13.63B

18,515.51%7.58B

59,124.43%1.48B

Earning before tax

65.11%5.97B

-2.45%5.28B

18.33%3.61B

3.74%5.41B

-18.66%3.05B

-71.92%5.21B

-65.80%3.75B

270.49%18.57B

320.56%10.98B

119.74%2.84B

Tax

-59.80%-981.32M

38.17%-492.92M

-23.31%-614.09M

-14.43%-797.27M

12.85%-497.99M

64.41%-696.72M

57.26%-571.39M

-191.19%-1.96B

-144.71%-1.34B

-106.47%-446.94M

After-tax profit from continuing operations

66.19%4.99B

3.73%4.78B

17.36%3B

2.09%4.61B

-19.70%2.56B

-72.81%4.52B

-66.98%3.18B

282.77%16.61B

367.10%9.64B

122.41%2.39B

After-tax profit from non-continuing business

----

225.96%1.58B

1,021.31%1.61B

0.06%484.76M

--143.29M

--484.47M

----

Earning after tax

8.23%4.99B

24.86%6.36B

70.65%4.61B

1.89%5.1B

-15.20%2.7B

-69.89%5B

-66.98%3.18B

282.77%16.61B

367.10%9.64B

122.41%2.39B

Minority profit

0.47%1.6B

3.59%2.86B

10.33%1.59B

12.46%2.77B

14.14%1.44B

22.56%2.46B

8.69%1.26B

27.83%2.01B

41.01%1.16B

139.53%480.92M

Profit attributable to shareholders

12.31%3.39B

50.08%3.5B

139.69%3.02B

-8.32%2.33B

-34.47%1.26B

-82.59%2.54B

-77.35%1.92B

427.17%14.61B

583.56%8.48B

118.49%1.91B

Basic earnings per share

14.83%0.1882

51.95%0.1913

141.74%0.1639

-7.83%0.1259

-34.17%0.0678

-82.45%0.1366

-77.19%0.103

428.02%0.7783

584.09%0.4515

118.67%0.1019

Diluted earnings per share

14.70%0.188

51.95%0.1913

141.74%0.1639

3.62%0.1259

-26.30%0.0678

-83.42%0.1215

-78.79%0.092

397.01%0.7326

557.27%0.4338

151.49%0.0928

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(Q1)Mar 31, 2021
Turnover	10.71%17.57B	10.18%28.87B	11.14%15.87B	0.67%26.2B	-5.99%14.28B	-3.11%26.03B	5.85%15.19B	13.59%26.86B	13.49%14.35B	16.41%7.24B
Operating income	10.71%17.57B	10.18%28.87B	11.14%15.87B	0.67%26.2B	-5.99%14.28B	-3.11%26.03B	5.85%15.19B	13.59%26.86B	13.49%14.35B	16.41%7.24B
Cost of sales	-8.31%-3.08B	-6.94%-5.34B	-9.42%-2.84B	-11.19%-4.99B	12.16%-2.6B	15.84%-4.49B	-7.50%-2.96B	-2.89%-5.33B	1.39%-2.75B	-11.75%-1.42B
Operating expenses	-8.31%-3.08B	-6.94%-5.34B	-9.42%-2.84B	-11.19%-4.99B	12.16%-2.6B	15.84%-4.49B	-7.50%-2.96B	-2.89%-5.33B	1.39%-2.75B	-11.75%-1.42B
Gross profit	11.24%14.49B	10.94%23.53B	11.52%13.03B	-1.53%21.21B	-4.50%11.68B	0.04%21.54B	5.46%12.23B	16.60%21.53B	17.70%11.6B	17.60%5.83B
Selling expenses	-11.27%-6.45B	-9.62%-10.08B	-11.03%-5.8B	6.28%-9.19B	9.23%-5.22B	6.74%-9.81B	-1.52%-5.75B	-17.23%-10.52B	-22.83%-5.67B	-22.58%-3.05B
Administrative expenses	-4.03%-1.09B	-11.12%-2.08B	-4.58%-1.05B	1.38%-1.87B	14.99%-1.01B	13.08%-1.9B	-4.97%-1.18B	17.72%-2.19B	-6.90%-1.13B	-1.69%-448.06M
Operating interest expense	----	----	----	----	----	----	-14.98%-169.27M	4.56%-308.62M	15.55%-147.22M	20.76%-71.66M
Special items of operating profit	51.71%-1.23B	-51.07%-6.18B	-34.58%-2.54B	-1.44%-4.09B	-0.61%-1.89B	-12.79%-4.03B	-48.22%-1.88B	-138.87%-3.58B	7.01%-1.27B	-38.40%-889.49M
Operating profit	57.31%5.72B	-14.23%5.19B	1.96%3.64B	4.40%6.05B	9.70%3.57B	17.31%5.8B	-4.19%3.25B	-1.48%4.94B	27.98%3.39B	5.76%1.36B
Financing income	66.89%373.58M	32.04%499.56M	--223.85M	--378.34M	----	----	----	----	----	----
Financing cost	19.86%-123.2M	40.41%-295.12M	47.61%-153.74M	-15.31%-495.24M	---293.43M	---429.49M	----	----	----	----
Share of profits of associates	94.82%-4.82M	77.50%-118.3M	57.59%-93.06M	-243.66%-525.71M	-143.61%-219.44M	-101.12%-152.98M	-93.37%503.16M	421,714.29%13.63B	18,515.51%7.58B	59,124.43%1.48B
Earning before tax	65.11%5.97B	-2.45%5.28B	18.33%3.61B	3.74%5.41B	-18.66%3.05B	-71.92%5.21B	-65.80%3.75B	270.49%18.57B	320.56%10.98B	119.74%2.84B
Tax	-59.80%-981.32M	38.17%-492.92M	-23.31%-614.09M	-14.43%-797.27M	12.85%-497.99M	64.41%-696.72M	57.26%-571.39M	-191.19%-1.96B	-144.71%-1.34B	-106.47%-446.94M
After-tax profit from continuing operations	66.19%4.99B	3.73%4.78B	17.36%3B	2.09%4.61B	-19.70%2.56B	-72.81%4.52B	-66.98%3.18B	282.77%16.61B	367.10%9.64B	122.41%2.39B
After-tax profit from non-continuing business	----	225.96%1.58B	1,021.31%1.61B	0.06%484.76M	--143.29M	--484.47M	----	----	----	----
Earning after tax	8.23%4.99B	24.86%6.36B	70.65%4.61B	1.89%5.1B	-15.20%2.7B	-69.89%5B	-66.98%3.18B	282.77%16.61B	367.10%9.64B	122.41%2.39B
Minority profit	0.47%1.6B	3.59%2.86B	10.33%1.59B	12.46%2.77B	14.14%1.44B	22.56%2.46B	8.69%1.26B	27.83%2.01B	41.01%1.16B	139.53%480.92M
Profit attributable to shareholders	12.31%3.39B	50.08%3.5B	139.69%3.02B	-8.32%2.33B	-34.47%1.26B	-82.59%2.54B	-77.35%1.92B	427.17%14.61B	583.56%8.48B	118.49%1.91B
Basic earnings per share	14.83%0.1882	51.95%0.1913	141.74%0.1639	-7.83%0.1259	-34.17%0.0678	-82.45%0.1366	-77.19%0.103	428.02%0.7783	584.09%0.4515	118.67%0.1019
Diluted earnings per share	14.70%0.188	51.95%0.1913	141.74%0.1639	3.62%0.1259	-26.30%0.0678	-83.42%0.1215	-78.79%0.092	397.01%0.7326	557.27%0.4338	151.49%0.0928
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	--
Auditor	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

No. Symbol 5D % Chg

Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.

Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More

年頭旺到年尾

Aug 21, 2025 06:11

Are you foolish? What's the point of knowing your mistakes?

牛牛課堂

Sep 12, 2025 17:29

[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?